Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 6Sarcoma 1

Conditions

Sarcoma 6Osteosarcoma 3Sarcoma, Ewing 2Chordoma 2Rhabdomyosarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Neoplasm Metastasis 1Mesothelioma 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colorectal Neoplasms 1Chondrosarcoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

trametinib 1sotorasib 1pembrolizumab 1palbociclib 1atezolizumab 1Pemetrexed 1Panitumumab 1Paclitaxel 1Everolimus 1Drug Therapy 1Docetaxel 1Carboplatin 1Bevacizumab 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Pemetrexed × Sarcoma × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡